: St. John s wort dry extract HRS

Similar documents
: Magnesium aspartate dihydrate CRS

: FOLIC ACID IMPURITY A CRS

: Human Immunoglobulin (Fc Function and Molecular size) BRP

: GLUTAMIC ACID CRS. Safety Data Sheet Safety Data Sheet in accordance to Regulation (EC) No. 1907/2006, as amended.

: HUMAN ALBUMIN FOR ELECTROPHORESIS BRP

: GLYCEROL MONOSTEARATE CRS

: ACESULFAME POTASSIUM IMPURITY B CRS

: SODIUM HYALURONATE BRP

: ACICLOVIR FOR SYSTEM SUITABILITY

: ASCORBIC ACID IMPURITY C CRS

: THIAMINE IMPURITY E CRS

Safety Data Sheet Safety Data Sheet in accordance to Regulation (EC) No. 1907/2006, as amended.

: AMBROXOL HYDROCHLORIDE CRS

: METAMIZOLE SODIUM CRS

: POVIDONE IODINATED CRS

: Exposure may produce an allergic reaction.

: ARGININE HYDROCHLORIDE CRS

: RIZATRIPTAN BENZOATE CRS

Safety Data Sheet Safety Data Sheet in accordance with Regulation (EC) No. 1907/2006, as amended.

: SALBUTAMOL IMPURITY B CRS

: VALSARTAN FOR PEAK IDENTIFICATION CRS

: CARVEDILOL FOR SYSTEM SUITABILITY CRS

: GLYCEROL FORMAL CRS

: MEPROBAMATE CRS. Safety Data Sheet Safety Data Sheet in accordance with Regulation (EC) No. 1907/2006, as amended.

: TRIAMCINOLONE HEXACETONIDE CRS

: SALBUTAMOL SULFATE CRS

: LISINOPRIL DIHYDRATE CRS

: THIOCTIC ACID CONTAINING IMPURITY B CRS

: VALSARTAN FOR SYSTEM SUITABILITY CRS

: PANTOPRAZOLE SODIUM SESQUIHYDRATE CRS

: FLUVASTATIN SODIUM CRS

: BETAMETHASONE 21-VALERATE CRS

: BENZYL ALCOHOL CRS

: CITALOPRAM HYDROCHLORIDE CRS

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

Safety Data Sheet Safety Data Sheet in accordance with Regulation (EC) No. 1907/2006, as amended.

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

: TETRACYCLINE HYDROCHLORIDE CRS

: PROGESTERONE IMPURITY C CRS

: METRONIDAZOLE CRS. Safety Data Sheet Safety Data Sheet in accordance with Regulation (EC) No. 1907/2006, as amended.

: ATROPINE IMPURITY B CRS

: PROMETHAZINE IMPURITY D CRS

: MELOXICAM IMPURITY C CRS

: CEFTRIAXONE IMPURITY A CRS

: 2.4-DICHLOROBENZYL ALCOHOL CRS

: Finixa cleaning wipes 150 x pcs.

MATERIAL SAFETY DATA SHEET (MSDS)

: PAROXETINE HYDROCHLORIDE (ANHYDROUS) IMPURITY C CRS

RUTIN (TRIHYDRATE) FOR BIOCHEMISTRY MSDS. CAS No: MSDS MATERIAL SAFETY DATA SHEET (MSDS)

MATERIAL SAFETY DATA SHEET (MSDS)

: CYCLOPHOSPHAMIDE CRS

: Protease (Subtilisin A from Bacillus licheniformis) Powder

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

: CITRIC ACID MONOHYDRATE CRS

: Acetic Acid Assay Kit (Acetate Kinase Analyser Format)

: Proteinase K (Molecular Biology Grade)

: URINAL BLOCKS (3KG)

: CYPROTERONE ACETATE CRS

: SODIUM ALENDRONATE CRS

SANITISER & DEGREASER

: MIDAZOLAM IMPURITY C CRS

: ADRENALINE TARTRATE CRS

: Tork Surface Cleaning Wet Wipes

: Attraction Purely Pink

: BisCem Base. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

10% DETERGENT 10% DETERGENT C071. Mon to Fri 8.30am to 5.00pm

: Citric Acid Assay Kit

Product name : CLEANLINE ECO - MILD WASHING UP LIQUID

: CHEMTREC - 24-Hour Hazmat Emergency Communications Center Domestic: Outside the U.S.: , collect calls accepted GHS07

SAFETY DATA SHEET. SECTION 1: Identification of the substance/mixture and of the company/undertaking

: CISPLATIN IMPURITY B CRS

: Tartrazine (C.I ) MIC

SAFETY DATA SHEET. SECTION 1: Identification of the substance/mixture and of the company/undertaking CHEMTREC

SAFETY DATA SHEET. SECTION 1: Identification of the substance/mixture and of the company/undertaking

Safety Data Sheet according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations

SAFETY DATA SHEET. SECTION 1: Identification of the substance/mixture and of the company/undertaking. CMP-NANA (CMP-N-Acetylneuraminic Acid)

1.2 Relevant identified uses of the substance or mixture and uses advised against Laboratory chemical

SASE SFS SPR3. Safety Data Sheet. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

SECTION 1: Identification of the substance/mixture and of the company/undertaking

: Pro 1 Oil Supplement

MATERIAL SAFETY DATA SHEET Issue Date: June 27, 2018

SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product Identifier

: AMS 5830, AMS 5848, SS316Li (Solids)

Transcription:

in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 14/05/2014 Supersedes: 01/10/2009 Version: 4.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product form : Substance Trade name : St. John s wort dry extract HRS EC no : 282-026-4 CAS No : 84082-80-4 Product code : Y0001050 1.2. Relevant identified uses of the substance or mixture and uses advised against 1.2.1. Relevant identified uses Main use category Use of the substance/mixture Function or use category : The product is intended for research, analysis and scientific education. : For professional use only : Laboratory chemicals 1.2.2. Uses advised against 1.3. Details of the supplier of the safety data sheet European Directorate for the Quality of Medicines & Healthcare EDQM, Council of Europe 67081 Strasbourg - France T +33(0)388412035 - F +33(0)388412771 www.edqm.eu 1.4. Emergency telephone number Emergency number : +44(0)1235239670 SECTION 2: Hazards identification 2.1. Classification of the substance or mixture Classification according to Regulation (EC) No. 1272/2008 [CLP] Classification according to Directive 67/548/EEC or 1999/45/EC Adverse physicochemical, human health and environmental effects 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] No labelling applicable 2.3. Other hazards Other hazards not contributing to the classification : Exposure may produce an allergic reaction. SECTION 3: Composition/information on ingredients 3.1. Substances Name Product identifier % Classification according to Directive 67/548/EEC St. John s wort dry extract (Main constituent) (CAS No) 84082-80-4 (EC no) 282-026-4 100 Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] St. John s wort dry extract (Main constituent) (CAS No) 84082-80-4 (EC no) 282-026-4 100 Full text of R-, H- and EUH-phrases: see section 16 14/05/2014 EN (English) 1/5

in accordance with Regulation (EC) No. 1907/2006, as amended. 3.2. Mixture SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures after inhalation First-aid measures after skin contact First-aid measures after eye contact : Move to fresh air. : Rinse with water. : Rinse eyes with water as a precaution. 4.2. Most important symptoms and effects, both acute and delayed Symptoms/injuries : None known. 4.3. Indication of any immediate medical attention and special treatment needed In all cases of doubt, or when symptoms persist, seek medical attention. SECTION 5: Firefighting measures 5.1. Extinguishing media Suitable extinguishing media 5.2. Special hazards arising from the substance or mixture Reactivity in case of fire : See Heading 10.1. : Small amounts: Use extinguishing media appropriate for surrounding fire. Large amounts: Not applicable. 5.3. Advice for firefighters Precautionary measures fire : Small amounts: Use normal individual fire protective equipment. Large amounts:. SECTION 6: Accidental release measures 6.1. Personal precautions, protective equipment and emergency procedures General measures 6.1.1. For non-emergency personnel 6.1.2. For emergency responders 6.2. Environmental precautions 6.3. Methods and material for containment and cleaning up Methods for cleaning up : Avoid raising dust. Avoid all unnecessary exposure. Large amounts:. : Sweep spilled substance into containers; if appropriate, moisten first to prevent dusting. Clean thoroughly. 6.4. Reference to other sections SECTION 7: Handling and storage 7.1. Precautions for safe handling Precautions for safe handling : Avoid all unnecessary exposure. 7.2. Conditions for safe storage, including any incompatibilities Storage conditions Incompatible products 7.3. Specific end use(s) See Heading 1. : To guarantee the quality and properties of the product, keep : dry, Keep in a cool, well-ventilated place away from heat. Store in original container. : Strong oxidizing agents. SECTION 8: Exposure controls/personal protection 8.1. Control parameters 8.2. Exposure controls SECTION 9: Physical and chemical properties 9.1. Information on basic physical and chemical properties Physical state : Solid Appearance : Powder. Amorphous. Solid. brown. 14/05/2014 EN (English) 2/5

in accordance with Regulation (EC) No. 1907/2006, as amended. Colour Odour Odour threshold ph Relative evaporation rate (butylacetate=1) Melting point Freezing point Boiling point Flash point Self ignition temperature Decomposition temperature Flammability (solid, gas) Vapour pressure Relative vapour density at 20 C Relative density Solubility Log Pow Viscosity, kinematic Viscosity, dynamic Explosive properties Oxidising properties Explosive limits 9.2. Other information SECTION 10: Stability and reactivity 10.1. Reactivity Stable under normal conditions. 10.2. Chemical stability 10.3. Possibility of hazardous reactions Small amounts: None known. Large amounts:. 10.4. Conditions to avoid 10.5. Incompatible materials Small amounts: None under normal use. Large amounts:. 10.6. Hazardous decomposition products When heated to decomposition, emits dangerous fumes. Large amounts:. SECTION 11: Toxicological information 11.1. Information on toxicological effects Acute toxicity Skin corrosion/irritation Serious eye damage/irritation Respiratory or skin sensitisation Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity (single exposure) Specific target organ toxicity (repeated exposure) Aspiration hazard Potential Adverse human health effects and symptoms : To our knowledge, the product does not present any particular risk, under normal conditions of use. Large amounts:. 14/05/2014 EN (English) 3/5

in accordance with Regulation (EC) No. 1907/2006, as amended. SECTION 12: Ecological information 12.1. Toxicity Ecology - general : Small amounts: Presents no specific risk for the environment. Large amounts:. 12.2. Persistence and degradability 12.3. Bioaccumulative potential 12.4. Mobility in soil 12.5. Results of PBT and vpvb assessment 12.6. Other adverse effects SECTION 13: Disposal considerations 13.1. Waste treatment methods SECTION 14: Transport information In accordance with ADR / RID / ADNR / IMDG / ICAO / IATA 14.1. UN number No dangerous good in sense of transport regulations 14.2. UN proper shipping name 14.3. Transport hazard class(es) 14.4. Packing group 14.5. Environmental hazards Dangerous for the environment Marine pollutant Other information : No : No : No supplementary information available. 14.6. Special precautions for user 14.6.1. Overland transport 14.6.2. Transport by sea 14.6.3. Air transport 14.6.4. Inland waterway transport 14.7. Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code SECTION 15: Regulatory information 15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture 15.1.1. EU-Regulations No REACH Annex XVII restrictions Seveso Information : 15.1.2. National regulations 14/05/2014 EN (English) 4/5

in accordance with Regulation (EC) No. 1907/2006, as amended. 15.2. Chemical safety assessment SECTION 16: Other information SDS EU (REACH Annex II) This information is based on our current knowledge and is intended to describe the product for the purposes of health, safety and environmental requirements only. It should not therefore be construed as guaranteeing any specific property of the product 14/05/2014 EN (English) 5/5